Skip to main content
. 2022 May 2;148:124–134. doi: 10.1016/j.jclinepi.2022.04.027

Table 2.

AI tools used in COVID-19 reviews: Table showing the different artificial intelligence (AI) tools that have been used in the elaboration of COVID-19 systematic reviews, according to their area of application: search assistance, randomized controlled trials (RCT) filtering and screening automation

Ref. Title Authors Journal AI used in… Software used Is open source?
[31] Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients with Coronavirus Disease 2019 Parasa et al. JAMA Network Open Search CORD-19 Partially
[32] The influence of comorbidity on the severity of COVID-19 disease: systematic review and analysis Zaki et al. Pre-print Search CORD-19 + Okapi BM25 Yes
[33] The Estimations of the COVID-19 Incubation Period: A Scoping Reviews of the Literature Zaki et al. Journal of Infection and Public Health Search CORD-19 + BioBERT Yes
[34] Ocular toxicity and Hydroxychloroquine: A Rapid Meta-Analysis Michelson et al. Pre-print Search GenesisAI (formerly Evid Science) No
[35] A Systematic Review of the Incubation Period of SARS-CoV-2: The Effects of Age, Biological Sex, and Location on Incubation Period Daley et al. Pre-print Search Not reported No
[36] Impact of remdesivir on 28 day mortality in hospitalized patients with COVID-19: February 2021 Meta-analysis Robinson et al. Pre-print RCT filtering RobotSearch Yes
[37] Impact of systemic corticosteroids on hospitalized patients with COVID-19: January 2021 Meta-analysis of randomized controlled trials Robinson et al. Pre-print RCT filtering RobotSearch Yes
[25] Prophylaxis against COVID-19: living systematic review and network meta-analysis Bartoszko et al. BMJ RCT filtering RobotSearch Yes
[26] Drug treatments for COVID-19: living systematic review and network meta-analysis Siemieniuk et al. BMJ RCT filtering RobotSearch Yes
[38] Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials Izcovich et al. Pre-print RCT filtering RobotSearch Yes
[39] Tocilizumab and sarilumab alone or in combination with corticosteroids for COVID-19: A systematic review and network meta-analysis Zeraatkar et al. Pre-print RCT filtering RobotSearch Yes
[40] Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality Honarmand et al. Journal of Clinical Epidemiology RCT filtering RobotSearch Yes
[41] Impacts of school closures on physical and mental health of children and young people: a systematic review Viner et al. Pre-print Screening EPPI-Reviewer No
[27] Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal Wynants et al. BMJ Screening EPPI-Reviewer No
[28] Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (Review) Dinnes et al. Cochrane Database of Systematic Reviews Screening EPPI-Reviewer No
[29] Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 Struyf et al. Cochrane Database of Systematic Reviews Screening EPPI-Reviewer No
[42] Are medical procedures that induce coughing or involve respiratory suctioning associated with increased generation of aerosols and risk of SARS-CoV-2 infection? A rapid systematic review Wilson et al. Journal of Hospital Infection Screening EPPI-Reviewer No
[43] Risk and Protective Factors in the COVID-19 Pandemic: A Rapid Evidence Map Elmore et al. Frontiers in Public Health Screening SWIFT-Active Screener No
[44] Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients: A Systematic Review and Meta-Analysis Alkofide et al. International Journal of Infectious Diseases Screening Abstrackr Yes
[30] Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Chu et al. The Lancet Screening Evidence Prime No